The renal pharmacology of metolazone, 2-methyl-3-O-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone.
D000138:Acidosis / Q000139:chemically induced; D000471:Alkalosis / Q000139:chemically induced; D000818:Animals; D002712:Chlorides / Q000378:metabolism; D004232:Diuretics / Q000494:pharmacology*; D004285:Dogs; D004339:Drug Compounding; D005260:Female; D005665:Furosemide / Q000494:pharmacology; D000882:Haplorhini; D006863:Hydrogen-Ion Concentration; D007659:Ketones / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects*; D007700:Kinetics; D008251:Macaca; D008297:Male; D009318:Natriuresis / Q000187:drug effects; D011188:Potassium / Q000378:metabolism; D011799:Quinazolines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D012964:Sodium / Q000378:metabolism; D013057:Spectrum Analysis; D013449:Sulfonamides / Q000494:pharmacology*; D014867:Water / Q000378:metabolism; D014882:Water-Electrolyte Balance / Q000187:drug effects
D002712:Chlorides; D004232:Diuretics; D007659:Ketones; D011799:Quinazolines; D013449:Sulfonamides; D014867:Water; D005665:Furosemide; D012964:Sodium; D011188:Potassium